Home › Atopic Dermatitis (Eczema) › Kentucky › Louisville
Atopic Dermatitis (Eczema) clinical trials in Louisville, KY
4 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Louisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Louisville
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Enveda Investigative Site, Louisville
- Enveda Investigative Site, Louisville
- Enveda Investigative Site, Clarksville · 3 mi away
- and 1 more
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- DS Research of Southern Indiana,LLC, Clarksville · 3 mi away
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- Southern Indiana Clinical Trials, New Albany · 4 mi away
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Los Angeles, CA11 studies
- Washington, DC11 studies
- San Antonio, TX10 studies
- San Diego, CA10 studies
- Birmingham, AL9 studies
- Miami, FL9 studies
- Dallas, TX8 studies
- Sacramento, CA8 studies
- Huntington Beach, CA8 studies
- Troy, MI8 studies
- Indianapolis, IN7 studies
Other studies in Louisville
- Non-Small Cell Lung Cancer22 studies
- Obesity17 studies
- Overweight15 studies
- Cancer (all types)14 studies
- Heart Failure13 studies
- Acute Myeloid Leukemia12 studies
- Multiple Myeloma12 studies
- Ovarian Cancer12 studies
- Breast Cancer11 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Lung Cancer11 studies
- Melanoma10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.